Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Given the FDAs April 2025 alert, informed consent for compounded topical finasteride should cover systemic absorption risk, known side effects (sexual, neuropsychiatric), transfer risk to household members (especially women of childbearing age), and the non-FDA-approved status of the formulation
Unsuccessful Diet Attempts If you have tried various diets and weight loss programs without lasting success, medical weight loss offers a medically-proven approach to achieve significant weight loss
10.1016/j.ejvs.2003.09.001 77 WatanabeY.KoyamaS.YamashitaA.MatsuuraY.NishihiraK.KitamuraK.et al (2018)
We proudly ship across Canada to qualified research institutions and laboratories
A typical transition timeline might look like this: Weeks 1-4: Start tirzepatide 2.5 mg weekly while maintaining phentermine at current dose Weeks 5-8: Increase tirzepatide to 5 mg weekly, reduce phentermine to 15 mg daily (if currently on a higher dose) Weeks 9-12: Increase tirzepatide to 7.5 mg weekly, begin tapering phentermine to every other day Week 13+: Discontinue phentermine, continue tirzepatide titration as needed This is a general framework, not a prescription
